Skip to content

Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity

Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05700409
Enrollment
100
Registered
2023-01-26
Start date
2023-01-01
Completion date
2025-01-23
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Childhood

Brief summary

The study objective is to evaluate whether a novel telemedicine-based intensive treatment program for children with obesity is superior to standard on-site care. This will be a randomized, non-blinded (due to the nature of the intervention) study, where 100 children and adolescents aged 10-18 years with obesity will be divided in a 1:1 ratio to either telemedicine or on-site treatments for 6 months. The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff. The in-office arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian. The main outcome of the study is BMI standard deviation (z-score) changes, which will be evaluated after 3 and 6 months of treatment during physical office visits in both study arms. Secondary outcomes will be: * Body-fat percent changes, assessed by bioimpedance analysis in physical clinic visits. * Daily step counts, measured by smartphone data/ wearable activity tracker, if available. * Weight-related quality of life * Retention and visit cancellation rates. * Satisfaction of both parent and child from their allocated treatment.

Interventions

BEHAVIORALIntensive lifestyle consultations

detailed above

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Obesity, defined as a BMI at or above 2 standard deviations SDs according to the WHO growth reference * Owning a smartphone, needed for video conversations, step counting and the gamification app * Parent consent and child's assent to participate in the program

Exclusion criteria

* Significant physical or mental barriers to physical activity and/or to dietary changes (such as autistic spectrum disorder that precludes dietary changes or sufficient exercise, as assessed by the PI)

Design outcomes

Primary

MeasureTime frameDescription
Weight statusFrom baseline to 3 monthsBMI z-score change

Secondary

MeasureTime frameDescription
Body-fat percent changesFrom baseline to 3 months
Daily step countsAt 3 months
Weight-related quality of lifeBaslineScores on the Impact of Weight on Quality of Life (IWQOL)-Kids questionnaire OR "Sizing me up" questionnaire
Visit cancellation rates6 months
Retention in program6 monthsDuration of participation in the program
Satisfaction of allocated treatment6 monthsGeneric PROM questionnaire used in our hopital

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026